Kallikrein protease activated receptor (PAR) axis: an attractive target for drug development

J Med Chem. 2012 Aug 9;55(15):6669-86. doi: 10.1021/jm300407t. Epub 2012 Jun 12.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Biomarkers, Tumor / metabolism
  • Central Nervous System Diseases / drug therapy
  • Central Nervous System Diseases / metabolism
  • Clinical Trials as Topic
  • Drug Design
  • Hormones / metabolism
  • Humans
  • Inflammation / drug therapy
  • Inflammation / metabolism
  • Kallikreins / antagonists & inhibitors
  • Kallikreins / metabolism*
  • Neoplasms / drug therapy
  • Neoplasms / metabolism
  • Peptides / chemistry
  • Peptides / pharmacology
  • Peptides / therapeutic use
  • Peptidomimetics / chemistry
  • Peptidomimetics / pharmacology
  • Peptidomimetics / therapeutic use
  • Receptors, Proteinase-Activated / agonists
  • Receptors, Proteinase-Activated / antagonists & inhibitors
  • Receptors, Proteinase-Activated / metabolism*
  • Skin Diseases / drug therapy
  • Skin Diseases / metabolism
  • Small Molecule Libraries

Substances

  • Biomarkers, Tumor
  • Hormones
  • Peptides
  • Peptidomimetics
  • Receptors, Proteinase-Activated
  • Small Molecule Libraries
  • Kallikreins